Clinical trials recruiting in Monserrato, Italy
11
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 3Phase 3 5Not applicable 3
Conditions recruiting in Monserrato, Italy
Recruiting trials in Monserrato, Italy
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
- Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
- PREgnancy and FERtility Registry
- Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Common questions
How many clinical trials are recruiting in Monserrato, Italy?
11 recruiting trials have at least one study site in Monserrato, Italy.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.